Drug
Bepirovirsen
Bepirovirsen: highest development phase Approved, developed by GlaxoSmithKline. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- GlaxoSmithKline
Trials
| Drug | Phase | Indication |
|---|---|---|
| HIBSAGO | Approved | |
| Bepirovirsen NCT06497504 | Phase 2 | Hepatitis B |
| Bepirovirsen NCT04954859 | Phase 2 | Hepatitis B |
Latest
- HIBSAGO approved by FDA
Follow Bepirovirsen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.